SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 27 filers reported holding SECOND SIGHT MED PRODS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $484,000 | -99.9% | 561,612 | 0.0% | 0.09% | +12.7% |
Q2 2020 | $550,211,000 | -1.5% | 561,612 | 0.0% | 0.08% | -48.4% |
Q1 2020 | $558,635,000 | -83.3% | 561,612 | -87.5% | 0.15% | -84.8% |
Q4 2019 | $3,336,034,000 | -10.0% | 4,492,975 | 0.0% | 1.00% | -29.9% |
Q3 2019 | $3,706,255,000 | +3.0% | 4,492,975 | 0.0% | 1.43% | +36.8% |
Q2 2019 | $3,597,974,000 | +0.7% | 4,492,975 | 0.0% | 1.05% | -11.0% |
Q1 2019 | $3,571,915,000 | -10.2% | 4,492,975 | 0.0% | 1.18% | -40.2% |
Q4 2018 | $3,978,529,000 | -53.4% | 4,492,975 | 0.0% | 1.97% | -32.2% |
Q3 2018 | $8,536,653,000 | +14.5% | 4,492,975 | 0.0% | 2.90% | +24.8% |
Q2 2018 | $7,458,339,000 | -13.5% | 4,492,975 | 0.0% | 2.33% | -15.7% |
Q1 2018 | $8,626,512,000 | +0.5% | 4,492,975 | 0.0% | 2.76% | -69.4% |
Q4 2017 | $8,581,582,000 | +59.2% | 4,492,975 | 0.0% | 9.03% | +120.0% |
Q3 2017 | $5,391,570,000 | -4.0% | 4,492,975 | 0.0% | 4.10% | -7.1% |
Q2 2017 | $5,616,219,000 | +3.3% | 4,492,975 | 0.0% | 4.42% | +11.7% |
Q1 2017 | $5,436,500,000 | – | 4,492,975 | – | 3.95% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,492,975 | $3,571,915,000 | 1.18% |
&PARTNERS | 51,961 | $41,000 | 0.06% |
Glassman Wealth Services | 72,366 | $58,000 | 0.02% |
Sigma Planning Corp | 385,737 | $307,000 | 0.02% |
Psagot Value Holdings Ltd. | 310,096 | $247,000 | 0.01% |
HBK Sorce Advisory LLC | 100,000 | $80,000 | 0.01% |
B. Riley Wealth Management, Inc. | 48,800 | $39,000 | 0.01% |
Fore Capital, LLC | 112,600 | $90,000 | 0.01% |
WealthTrust Axiom LLC | 17,320 | $13,000 | 0.01% |
Semmax Financial Advisors Inc. | 7,290 | $6,000 | 0.00% |